This inventor holds 1 USPTO granted patent and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Medimmune Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2019
Title: David Edwin Gruber: Innovator in Polypeptide Purification
Introduction
David Edwin Gruber is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of biotechnology, particularly in the purification of recombinantly produced polypeptides. His innovative methods have the potential to enhance the efficiency of protein purification processes.
Latest Patents
Gruber holds a patent for the "Purification of recombinantly produced polypeptides." This patent describes a method for separating a recombinantly produced polypeptide from host cell protein. The method involves loading a clarified cell culture supernatant containing the polypeptide and host cell proteins onto a Protein A chromatography column. It includes a washing step with a wash buffer that comprises a fatty acid with a chain length of at least about 6 carbon atoms, or a fatty acid salt, to effectively remove host cell proteins and recover the desired polypeptide.
Career Highlights
David Gruber is associated with Medimmune Limited, where he applies his expertise in biotechnology and protein purification. His work at Medimmune Limited has positioned him as a key player in the development of innovative biopharmaceutical solutions.
Collaborations
Gruber has collaborated with notable colleagues, including Richard Edward Turner and Jared Samuel Bee. These collaborations have likely contributed to the advancement of research and development in their respective fields.
Conclusion
David Edwin Gruber's contributions to the purification of recombinantly produced polypeptides highlight his innovative spirit and dedication to advancing biotechnology. His work continues to influence the industry and pave the way for future advancements in protein purification techniques.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile